How Providers Are Adopting Neuromodulation for PDN Treatment
Healthcare providers across specialties are incorporating neuromodulation into their chronic pain treatment offerings. Learn why clinics are choosing NeuroDynamics Global's turnkey approach.
A Growing Trend in Pain Management
As the medical community increasingly seeks non-opioid alternatives for chronic pain, neuromodulation therapy is gaining traction among healthcare providers treating painful diabetic neuropathy (PDN). From pain management specialists to podiatrists, providers across specialties are exploring how this technology can enhance their treatment offerings.
Why Providers Are Making the Switch
Addressing Unmet Patient Needs An estimated 26% of diabetes patients develop painful neuropathy. Many have tried multiple medications with limited relief, creating demand for new approaches.
Non-Opioid Positioning With opioid prescribing under increased scrutiny, providers are looking for evidence-based alternatives. NeuroDynamics Global therapy offers an FDA-cleared, drug-free option that aligns with current pain management guidelines.
Revenue Diversification Adding neuromodulation to a practice can create a new service line with established reimbursement pathways. NeuroDynamics Global provides comprehensive revenue cycle management support.
The Turnkey Provider Model
NeuroDynamics Global has designed its provider program to minimize barriers to adoption:
Comprehensive Training Full clinical training covers device implantation technique, patient selection criteria, and follow-up protocols. Training is provided on-site at your practice.
Dedicated Clinical Liaison Each practice receives a dedicated point of contact for clinical questions, troubleshooting, and ongoing support.
Reimbursement Guidance NeuroDynamics Global's team assists with prior authorization, coverage verification, claims submission, and appeals when needed.
Outcomes Tracking Built-in tools help providers monitor patient outcomes and demonstrate program value.
Which Specialties Are Adopting?
NeuroDynamics Global therapy is being adopted across multiple specialties:
- Pain Management
- Neurology
- Podiatry
- Primary Care
- Endocrinology
- Physical Medicine & Rehabilitation
Getting Started
Providers interested in adding NeuroDynamics Global therapy to their practice can schedule a 15-minute program fit call to learn about implementation, training, and the reimbursement landscape.
Coverage is payer- and patient-specific. Contact NeuroDynamics Global for current reimbursement information.
Important medical disclaimer. This content is for general informational and educational purposes only and is not medical advice, diagnosis, or treatment. It does not establish a physician–patient relationship. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or therapy.
About NS100 by NeuroDynamics Global. NS100 is an FDA-cleared Class II peripheral nerve stimulation medical device for chronic pain associated with painful diabetic neuropathy. Use of NS100 requires evaluation and prescription by a qualified healthcare provider. As with any medical device, NS100 carries potential risks; your provider will review indications, contraindications, and possible side effects with you.
Results vary. Individual results and experiences with NS100 vary from patient to patient. No specific outcome is guaranteed. Coverage and reimbursement are payer- and plan-specific.
Related Articles
Alternatives to Gabapentin for Diabetic Neuropathy: An Evidence-Based Provider Guide
A review for providers on the limitations of gabapentinoids and the evidence for pharmacological and interventional alternatives for managing painful diabetic neuropathy.
Read NeuromodulationNeurowellness Wearables and Diabetic Nerve Pain: What Consumer EEG and Vagus-Nerve Devices Can (and Cannot) Do
Consumer neurowellness wearables — ear-EEG headbands, vagus-nerve stimulators like Pulsetto and Elemind — are having a mainstream moment in 2026. Here is a plain-language look at what they actually do, what the evidence shows for diabetic nerve pain, and where medical neuromodulation is a different category entirely.
Read treatmentTENS Units and Diabetic Neuropathy: What They Do, Their Limits, and When to Consider Medical Neuromodulation
A straight answer on whether a TENS unit can help diabetic nerve pain — what the device actually does, where the evidence stops, and when a physician-directed option may fit better.
Read educationBeyond Gabapentin: Drug-Free Options for Diabetic Neuropathy Relief
Gabapentin is a common first-line oral medication for painful diabetic neuropathy, but many patients don't get adequate relief or can't tolerate the side effects. Here's a plain-language look at drug-free options — including the FDA-cleared NS100 by NeuroDynamics Global.
ReadWant to learn more?
Talk to your healthcare provider or contact NeuroDynamics Global today.